Wiskott-Aldrich Syndrome (Eczema-thrombocytopenia) (WAS) (AA 57-170) antibody Primary Antibody
WAS Reactivity: Human ELISA, FACS, IHC, WB Host: Mouse Monoclonal 7B10E4
Catalog No. ABIN5542679
Plus shipping costs $45.00
local_shipping Shipping to: United States
Delivery in 3 to 4 Business Days
- Binding Specificity
- AA 57-170
- ELISA, Flow Cytometry (FACS), Immunohistochemistry (IHC), Western Blotting (WB)
- Purified recombinant fragment of human WAS (AA 57-170) expressed in E. Coli.
- Application Notes
- ELISA: 1:10000, WB: 1:500 - 1:2000, IHC: 1:200 - 1:1000, FCM: 1:200 - 1:400
- For Research Use only
- PBS with 0.05 % sodium azide.
- 4 °C,-20 °C
- Storage Comment
- 4°C, -20°C for long term storage
- Alternative Name
- WAS (WAS Antibody Abstract)
- The Wiskott-Aldrich syndrome (WAS) family of proteins share similar domain structure, and are involved in transduction of signals from receptors on the cell surface to the actin cytoskeleton. The presence of a number of different motifs suggests that they are regulated by a number of different stimuli, and interact with multiple proteins. Recent studies have demonstrated that these proteins, directly or indirectly, associate with the small GTPase, Cdc42, known to regulate formation of actin filaments, and the cytoskeletal organizing complex, Arp2/3. Wiskott-Aldrich syndrome is a rare, inherited, X-linked, recessive disease characterized by immune dysregulation and microthrombocytopenia, and is caused by mutations in the WAS gene. The WAS gene product is a cytoplasmic protein, expressed exclusively in hematopoietic cells, which show signalling and cytoskeletal abnormalities in WAS patients. A transcript variant arising as a result of alternative promoter usage, and containing a different 5' UTR sequence, has been described, however, its full-length nature is not known.
- Molecular Weight
You are here: